Market closed

IceCure Medical/$ICCM

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About IceCure Medical

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Ticker

$ICCM

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

Caesarea, Israel

Employees

Website

www.icecure-medical.com

IceCure Medical Metrics

BasicAdvanced

$64M

-

-$0.29

2.63 -

Price and volume

Market cap

$64M

Beta

2.63

52-week high

$1.57

52-week low

$0.48

Average daily volume

453K

Financial strength

Current ratio

2.67

Quick ratio

2.164

Long term debt to equity

2.207

Total debt to equity

4.831

Management effectiveness

Return on assets (TTM)

-52.54%

Return on equity (TTM)

-111.35%

Valuation

Price to revenue (TTM)

15.458

Price to book

6.4

Price to tangible book (TTM)

6.4

Price to free cash flow (TTM)

-5.259

Growth

Revenue change (TTM)

26.02%

Earnings per share change (TTM)

-19.95%

3-year revenue growth (CAGR)

-5.38%

3-year earnings per share growth (CAGR)

-3.94%

What the Analysts think about IceCure Medical

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for IceCure Medical stock.

IceCure Medical Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

IceCure Medical Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

IceCure Medical News

AllArticlesVideos

IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ICCM

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IceCure Medical stock?

IceCure Medical (ICCM) has a market cap of $64M as of January 15, 2025.

What is the P/E ratio for IceCure Medical stock?

The price to earnings (P/E) ratio for IceCure Medical (ICCM) stock is 0 as of January 15, 2025.

Does IceCure Medical stock pay dividends?

No, IceCure Medical (ICCM) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next IceCure Medical dividend payment date?

IceCure Medical (ICCM) stock does not pay dividends to its shareholders.

What is the beta indicator for IceCure Medical?

IceCure Medical (ICCM) has a beta rating of 2.63. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.